Search

Author/Creator Stokes, Kerrie

1. Bortezomib with high dose melphalan conditioning for autologous transplant is safe and effective in patients with heavily pretreated and high risk multiple myeloma. Issue 7 (1st July 2013)

Authors:
Wong Doo, Nicole; Thompson, Philip A.; Prince, H. Miles; Seymour, John F.; Ritchie, David; Stokes, Kerrie; Burbury, Kate; Wolf, Max; Joyce, Trish; Harrison, Simon J.
Journal:
Leukemia & lymphoma
Issue:
Volume 54:Issue 7(2013:Jul.)
Page Start:
1465
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Bortezomib with high dose melphalan conditioning for autologous transplant is safe and effective in patients with heavily pretreated and high risk multiple myeloma. Issue 7 (July 2013)

Authors:
Wong Doo, Nicole; Thompson, Philip A.; Prince, H. Miles; Seymour, John F.; Ritchie, David; Stokes, Kerrie; Burbury, Kate; Wolf, Max; Joyce, Trish; Harrison, Simon J.
Journal:
Leukemia & lymphoma
Issue:
Volume 54:Issue 7(2013:Jul.)
Page Start:
1465
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search